ZHOU MINGDONG has a total of 12 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SURVAC APS, CT MOLECULAR MED & IMMUNOLOGY and ONTARIO INC 1149336.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | China | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Computer technology | |
#6 | Semiconductors | |
#7 | Medical technology | |
#8 | Materials and metallurgy |
# | Name | Total Patents |
---|---|---|
#1 | Zhou Mingdong | 12 |
#2 | Qiu Liequn | 1 |
Publication | Filing date | Title |
---|---|---|
US2013079281A1 | Neuregulin based methods for treating heart failure | |
US2011230412A1 | Neuregulin peptides and their use | |
US2008260713A1 | Neukinase, a downstream protein of neuregulin | |
US2007213264A1 | Neuregulin variants and methods of screening and using thereof | |
CN1352391A | Novel anti-tumor medicine and its screening method and use | |
CN1276381A | Application of growth factor neuregulin and its analogs |